Search Results - "Biggin, Colin"

Positron emission tomography of patients with confirmed prostate cancer using 64 Cu-SAR-bisPSMA by Emmett, Louise, Wong, Veronica, Lenzo, Nat, Lengyelova, Eva, Biggin, Colin

“…318 Background: Prostate cancer (PC) is the second most frequent malignancy in men worldwide. 68 Ga-PSMA-11 is one of the most widely used radiotracers for…”
Get full text

The case for centralised manufacture of cGMP-grade radiopharmaceuticals- Current and Next Generation Theranostics by Biggin, Colin, Jeffery, Charmaine, Harris, Matt

“…Objectives: To examine the suitability of centralised manufacture (metro and regional) of both current and Next Generation Theranostic radiopharmaceuticals for…”
Get full text

Time-Efficient Method for the Determination of 210Pb, 210Bi, and 210Po Activities in Seawater Using Liquid Scintillation Spectrometry by Biggin, Colin D, Cook, Gordon T, MacKenzie, Angus B, Pates, Jacqueline M

“…A novel method has been developed for determining the natural decay series radionuclides (NDS), 210Pb, 210Bi, and 210Po, in seawater by way of state-of-the-art…”
Get full text

Radiological properties of Next Generation Theranostics (Cu-64/Cu-67) by Biggin, Colin, Harris, Matt, Hedt, Amos, Jeffery, Charmaine

“…Objectives: To examine the radiological properties of Next Generation Theranostics: Methods: Next generation theranostics can potentially offer improvements on…”
Get full text

64Cu Treatment Planning and 67Cu Therapy with Radiolabeled [64Cu/67Cu]MeCOSar-Octreotate in Subjects with Unresectable Multifocal Meningioma: Initial Results for Human Imaging, Safety, Biodistribution, and Radiation Dosimetry by Bailey, Dale L, Willowson, Kathy P, Harris, Matthew, Biggin, Colin, Aslani, Alireza, Lengkeek, Nigel A, Stoner, Jon, Eslick, M Enid, Marquis, Harry, Parker, Michelle, Roach, Paul J, Schembri, Geoffrey P

“…Our aim was to report the use of 64Cu and 67Cu as a theranostic pair of radionuclides in human subjects. An additional aim was to measure whole-organ dosimetry…”
Get full text

Development of 67Cu quantitative SPECT for clinical dosimetry by Willowson, Kathy, Harris, Matt, Jeffery, Charmaine, Biggin, Colin, Hedt, Amos, Stoner, Jon, Bailey, Dale

“…Objectives: ackground / Aims: Copper-67 (67Cu) shows promise as a radionuclide therapy agent, in particular when paired with the diagnostic PET imaging agent…”
Get full text

Development of ^sup 67^Cu quantitative SPECT for clinical dosimetry by Willowson, Kathy, Harris, Matt, Jeffery, Charmaine, Biggin, Colin, Hedt, Amos, Stoner, Jon, Bailey, Dale

“…Objectives: ackground / Aims: Copper-67 (67Cu) shows promise as a radionuclide therapy agent, in particular when paired with the diagnostic PET imaging agent…”
Get full text

64 Cu Treatment Planning and 67 Cu Therapy with Radiolabeled [ 64 Cu/ 67 Cu]MeCOSar-Octreotate in Subjects with Unresectable Multifocal Meningioma: Initial Results for Human Imaging, Safety, Biodistribution, and Radiation Dosimetry by Bailey, Dale L, Willowson, Kathy P, Harris, Matthew, Biggin, Colin, Aslani, Alireza, Lengkeek, Nigel A, Stoner, Jon, Eslick, M Enid, Marquis, Harry, Parker, Michelle, Roach, Paul J, Schembri, Geoffrey P

“…Our aim was to report the use of Cu and Cu as a theranostic pair of radionuclides in human subjects. An additional aim was to measure whole-organ dosimetry of…”
Get full text

Harnessing 64 Cu/ 67 Cu for a theranostic approach to pretargeted radioimmunotherapy by Keinänen, Outi, Fung, Kimberly, Brennan, James M, Zia, Nicholas, Harris, Matt, van Dam, Ellen, Biggin, Colin, Hedt, Amos, Stoner, Jon, Donnelly, Paul S, Lewis, Jason S, Zeglis, Brian M

“…Over the past decade, theranostic imaging has emerged as a powerful clinical tool in oncology for identifying patients likely to respond to targeted therapies…”
Get full text

Harnessing 64Cu/67Cu for a theranostic approach to pretargeted radioimmunotherapy by Keinänen, Outi, Fung, Kimberly, Brennan, James M., Zia, Nicholas, Harris, Matt, van Dam, Ellen, Biggin, Colin, Hedt, Amos, Stoner, Jon, Donnelly, Paul S., Lewis, Jason S., Zeglis, Brian M.

“…Over the past decade, theranostic imaging has emerged as a powerful clinical tool in oncology for identifying patients likely to respond to targeted therapies…”
Get full text

Radiation Safety Considerations for the Use of 223RaCl2 DE in Men with Castration-resistant Prostate Cancer by Dauer, Lawrence T, Williamson, Matthew J, Humm, John, O’Donoghue, Joseph, Ghani, Rashid, Awadallah, Robert, Carrasquillo, Jorge, Pandit-Taskar, Neeta, Aksnes, Anne-Kirsti, Biggin, Colin, Reinton, Vigdis, Morris, Michael, St. Germain, Jean

“…ABSTRACTThe majority of patients with late stage castration-resistant prostate cancer (CRPC) develop bone metastases that often result in significant bone…”
Get full text

RADIATION SAFETY CONSIDERATIONS FOR THE USE OF super(223)RaCl sub(2) DE IN MEN WITH CASTRATION-RESISTANT PROSTATE CANCER by Dauer, Lawrence T, Williamson, Matthew J, Humm, John, O'Donoghue, Joseph, Ghani, Rashid, Awadallah, Robert, Carrasquillo, Jorge, Pandit-Taskar, Neeta, Aksnes, Anne-Kirsti, Biggin, Colin, Reinton, Vigdis, Morris, Michael, St Germain, Jean

“…The majority of patients with late stage castrationresistant prostate cancer (CRPC) develop bone metastases that often result in significant bone pain…”
Get full text

Time-Efficient Method for the Determination of 210 Pb, 210 Bi, and 210 Po Activities in Seawater Using Liquid Scintillation Spectrometry by Biggin, Colin D., Cook, Gordon T., MacKenzie, Angus B., Pates, Jacqueline M.

Get full text

Development of a Time Efficient Method for the Determination of 210Pb, 210Bi and 210Po Activities in Seawater by Liquid Scintillation Spectrometry by Biggin, Colin David

“…A time efficient method has been developed for the determination of the natural decay series radionuclides, 210Pb, 210Bi and 210Po in dissolved and particle…”
Get full text